A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission
Open Access
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (12), 1467-1474
- https://doi.org/10.1023/a:1008328012040
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursBritish Journal of Cancer, 1999
- High-dose chemotherapy with autologous stem cell support in poor-risk germ cell tumorsAnnals of Hematology, 1998
- Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.Journal of Clinical Oncology, 1997
- Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancerCancer, 1997
- High-dose chemotherapy in germ-cell tumorsAnnals of Oncology, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Late relapse of testicular cancer.Journal of Clinical Oncology, 1995
- High-dose chemotherapy regimens for solid tumorsCancer Treatment Reviews, 1995
- Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantion incorporating carboplatin, cyclophosphamide and thiotepaAnnals of Oncology, 1992
- Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow RescueAnnals of Internal Medicine, 1992